Abstract

A replacement for valproate — a longstanding established drug of choice for the treatment of generalized epilepsies — has been sought for decades.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call